March 10 (Reuters) – Medical device maker Medtronic said on Tuesday it has agreed to buy U.S.-based Scientia Vascular in a deal valued at $550 million, aiming to expand its line-up of products used in stroke care.
Here are some details:
(Reporting by Sahil Pandey in Bengaluru; Editing by Jonathan Ananda)
